SCHEMBL7430552

SCHEMBL7430552

CC(NC(=O)C(O)C(CC(F)(F)F)N(C=O)OC(C)(C)C)c1ccc2ccccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.44
METAP1 P53582 1/20 0.44
MMP9 P14780 2/20 0.41
SLC6A2 P23975 5/20 0.37
SLC6A4 P31645 5/20 0.37
SLC6A3 Q01959 5/20 0.37
CYP2D6 P10635 1/20 0.37
HCRTR1 O43613 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP17A1 P05093 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
PDE2A O00408 1/20 0.35
UTS2R Q9UKP6 2/20 0.34
MMP8 P22894 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRB2 P47870 1/20 0.34
KCNH2 Q12809 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7430561 1.00 METAP2 (0.44) METAP2METAP1MMP9SLC6A2SLC6A4
SCHEMBL7434780 0.89 UTS2R (0.38) METAP2METAP1SLC6A2SLC6A4SLC6A3
SCHEMBL7434771 0.89 UTS2R (0.38) METAP2METAP1SLC6A2SLC6A4SLC6A3
SCHEMBL7442501 0.88 MEN1 (0.41) MMP9MEN1KMT2AMMP8
SCHEMBL7443197 0.82 MMP9 (0.47) METAP2METAP1MMP9SLC6A2SLC6A4
SCHEMBL7443211 0.82 MMP9 (0.47) METAP2METAP1MMP9SLC6A2SLC6A4
SCHEMBL7440649 0.81 TSHR (0.36) MEN1KMT2A
SCHEMBL7441757 0.81 POLB (0.37) MEN1KMT2A
SCHEMBL7429954 0.79 ALDH1A1 (0.37) METAP2METAP1
SCHEMBL7442611 0.79 ALDH1A1 (0.37) METAP2METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187905-B1 PEPTIDE COMPOUND WHICH INHIBITS VIRAL PROTEINASES; VIRICIDES FOR HEPATITIS C, HEPATITIS G, AND HUMAN GB VIRUSES HOFFMANN-LA ROCHE INC. 2001-02-13 US disclosed